Replies to post #710928 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Parliament approved approximately &375 million about two years ago for interim funding for therapies such as ours. That's why the company is not worried about reimbursement from NICE for the automated system as of now. That money should cover the first year of our operation's charges.

No. There is 340M GPB for the CDF is something that NICE can recommend be used after they perform an appraisal if they decide they need more evidence. It also is used t bridge the paperwork gap between NICE opinion and formal NIH funding.

Point being is that CDF cash is AFTER the NICE evaluation either way.

Further, it is already funding lot of drugs and it rations out funds.